Skip to main content
The BMJ logoLink to The BMJ
letter
. 1992 Aug 15;305(6850):421–422. doi: 10.1136/bmj.305.6850.421-b

Frequency of citation and outcome of cholesterol lowering trials.

J Anderson
PMCID: PMC1883135  PMID: 1392934

Full text

PDF
421

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Frick M. H., Elo O., Haapa K., Heinonen O. P., Heinsalmi P., Helo P., Huttunen J. K., Kaitaniemi P., Koskinen P., Manninen V. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987 Nov 12;317(20):1237–1245. doi: 10.1056/NEJM198711123172001. [DOI] [PubMed] [Google Scholar]
  2. Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ. 1992 Jul 4;305(6844):15–19. doi: 10.1136/bmj.305.6844.15. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES